276 related articles for article (PubMed ID: 12362770)
1. [Apropos the National Board and Welfare's report on ADDH: some views on the treatment with central nervous system stimulants].
Zetterström R
Lakartidningen; 2002 Aug; 99(35):3435-6. PubMed ID: 12362770
[No Abstract] [Full Text] [Related]
2. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
Janols LO; Liliemark J; Klintberg K; von Knorring AL
Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
[TBL] [Abstract][Full Text] [Related]
3. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
Merkel RL; Kuchibhatla A
Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
[TBL] [Abstract][Full Text] [Related]
4. [Medication for ADHD and the risk of cardiovascular mortality].
Kalverdijk LJ; Buitelaar JK; van der Gaag RJ
Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2283-4; author reply 2284. PubMed ID: 17078147
[No Abstract] [Full Text] [Related]
5. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
6. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
7. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
Pelz R; Banaschewski T; Becker K
Klin Padiatr; 2008; 220(2):93-100. PubMed ID: 18157763
[TBL] [Abstract][Full Text] [Related]
8. Improving decision making in the treatment of ADHD.
Vitiello B
Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
[No Abstract] [Full Text] [Related]
9. Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
[No Abstract] [Full Text] [Related]
10. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
Harpin VA
Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
[TBL] [Abstract][Full Text] [Related]
11. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
12. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
13. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
Killeen MR
J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
[No Abstract] [Full Text] [Related]
14. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
Ghanizadeh A
J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
[TBL] [Abstract][Full Text] [Related]
16. Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
Gerlach M; Grünblatt E; Lange KW
Atten Defic Hyperact Disord; 2013 Jun; 5(2):71-81. PubMed ID: 23605387
[TBL] [Abstract][Full Text] [Related]
17. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
18. [The costs of drugs against ADDH should be reduced].
Rise L
Lakartidningen; 2003 Jun; 100(26-27):2316; author reply 2316. PubMed ID: 12872384
[No Abstract] [Full Text] [Related]
19. Children's self-reports on perceived effects on taking stimulant medication for ADHD.
Thorell LB; Dahlström K
J Atten Disord; 2009 Mar; 12(5):460-8. PubMed ID: 18685139
[TBL] [Abstract][Full Text] [Related]
20. Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk.
Gadow KD; Sverd J
J Dev Behav Pediatr; 1990 Oct; 11(5):269-71; discussion 272. PubMed ID: 1979565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
